Childhood Blood Cancer Treatment in Mumbai, India

Childhood blood cancer is a serious illness that requires timely and appropriate treatment. In Mumbai, the importance of early detection, accurate diagnosis, and choosing the right childhood blood cancer surgeon cannot be overstated. In this blog post, we will explore the significance of these factors in ensuring the best possible outcomes for children with blood cancer.

Early detection plays a crucial role in effectively treating childhood blood cancer. It allows for prompt intervention and increases the chances of successful treatment. Some key points to consider regarding early detection and diagnosis include:

Awareness: Parents and caregivers should be aware of the signs and symptoms of childhood blood cancer, such as unexplained weight loss, persistent fever, fatigue, and easy bruising or bleeding. By recognising these symptoms early on, they can seek medical attention promptly.

Regular check-ups: Routine visits to medical practitioners are essential for monitoring a child's health. Regular check-ups can help detect any abnormalities or signs of blood cancer at an early stage.

Experience: One should seek a surgeon who specialises in pediatric oncology and has extensive experience in treating childhood blood cancer patients. Their expertise will ensure that the child receives the best possible care.

Collaborative approach: A multidisciplinary team is crucial for comprehensive childhood blood cancer treatment. Choose a surgeon who works closely with other specialists like pediatric haematologists, radiologists, and pathologists to provide holistic care.

Supportive environment: The hospital where the surgeon practices should have a child-friendly environment that offers emotional support for both children and their families during treatment.

Thus, one should not underestimate the significance of timely and appropriate childhood blood cancer treatment in Mumbai when striving for positive results. Detecting and diagnosing the condition early is essential, as is selecting the right paediatric oncologist. If there are any symptoms or concerns about a child's health, it is advisable to consult a healthcare professional promptly. It is important to remember that taking early action can significantly influence a child's chances of recovery.

Alternative Names for Childhood Blood Cancer

In India, cancer is the ninth leading cause of death for children aged 5 to 14, with around 45,000 new cases diagnosed each year. Childhood blood cancer, also known as childhood leukaemia, is a devastating disease that affects children of all ages. It is a type of cancer that affects the bone marrow and blood cells, causing them to grow uncontrollably. While childhood leukaemia is the most common type of childhood blood cancer, there are other names used to describe this condition. Some alternative names for childhood blood cancer include:

1. Pediatric Leukaemia
2. Juvenile Leukaemia
3. Children's Leukaemia
4. Acute Lymphoblastic Leukaemia (ALL)
5. Acute Myeloid Leukaemia (AML)

These alternative names may be used interchangeably depending on the specific type and subtype of childhood blood cancer diagnosed in a child. It's important to understand that regardless of the name used, the impact on a child and their family is significant.

Childhood Leukaemia or Blood Cancer Types

There are different types of childhood leukaemia, each with its own characteristics and treatment options. In this article, we will explore the four main types of childhood leukaemia: Acute lymphoblastic Leukaemia (ALL), Chronic lymphocytic Leukaemia (CLL), Acute myelogenous Leukaemia (AML), and Chronic myelogenous Leukaemia (CML).

Acute Lymphoblastic Leukaemia (ALL)

ALL is the most common type of childhood leukaemia.

It primarily affects lymphoid cells, which are responsible for producing immune cells.

Symptoms may include fatigue, pale skin, easy bruising or bleeding, frequent infections, joint pain, and swollen lymph nodes.

The primary types of ALL are B-cell ALL and T-cell ALL, named after the specific blood cells they affect.

1. B-cell ALL: This type affects B-cells, which help fight infections by making antibodies. B-cell ALL is the most common, accounting for about 75% to 80% of all childhood leukaemia cases.
2. T-cell ALL: This type impacts T-cells, which play a role in destroying germs and supporting the immune system. T-cell ALL is less common than B-cell ALL.
3. Natural Killer ALL: This is a very rare type of childhood leukaemia.

ALL can occur in children of any age but is more prevalent between the ages of 2 and 5.

The mainstay of treatment for childhood ALL is chemotherapy, aimed at achieving remission.

Chronic Lymphocytic Leukaemia (CLL) 

CLL is relatively rare in children and more commonly found in adults.

It develops from abnormal lymphocytes that multiply and accumulate in the bone marrow and blood.

CLL often progresses slowly, and many children may not require immediate treatment.

Symptoms may include enlarged lymph nodes, fatigue, recurrent infections, easy bruising or bleeding, and weight loss.

Acute Myelogenous Leukaemia (AML)

AML accounts for about 10% of all leukaemia cases in children less than 10 years of age, and for 25-30% between 10 and 15 years in India.

It starts in the bone marrow where abnormal myeloid cells grow rapidly, crowding out healthy blood cells.

Common symptoms include fatigue, shortness of breath, pale skin, easy bruising or bleeding, frequent infections, fever, and bone pain.

AML can occur in children of any age, but it is more common in older children and teenagers.

Treatment for childhood AML involves chemotherapy, which aims to induce remission by eliminating cancerous cells. Stem cell transplantation may be considered in certain cases, especially if there is a high risk of relapse.

Chronic Myelogenous Leukaemia (CML) 

CML is extremely rare in children and primarily affects adults.

It occurs when white blood cells develop an abnormal chromosome called the Philadelphia chromosome.

Symptoms may include fatigue, weight loss, abdominal pain or fullness, fever, bone pain, and night sweats.

Treatment for CML in children often involves targeted therapies to inhibit the growth of cancer cells.

While the diagnosis of childhood leukaemia can be devastating for families, it is important to remember that advancements in treatments have significantly improved survival rates. Research and clinical trials are constantly exploring new treatment options to further improve outcomes for these young patients.

Preparing for Childhood Blood Cancer Treatment 

Getting ready for childhood blood cancer treatment involves a holistic approach, like seeing the doctors, feeling better emotionally, and getting help with money and support for the family. Let's explore these vital aspects.

Medical Evaluation and Tests

When a child is diagnosed with childhood blood cancer, the first step in preparing for treatment is undergoing a thorough medical evaluation and tests. This is done to determine the extent of the disease and develop an appropriate treatment plan. Here are some key points to consider:

Medical evaluation: The child will undergo physical examinations and medical history reviews to assess their overall health and identify any specific factors that may affect treatment.

Diagnostic tests: Various tests will be conducted to confirm the diagnosis, including blood tests, bone marrow aspiration, and imaging scans such as X-rays or Magnetic Resonance Imaging (MRI).

Staging: Staging helps determine the stage of cancer and how far it has spread. It helps doctors plan the most effective treatment approach.

Emotional Support for the Child and Family 

A diagnosis of childhood blood cancer can be overwhelming for both the child and their family. Emotional support plays a crucial role in helping them cope throughout the treatment journey. Here's how one can provide emotional support:

Open communication: Encourage open and honest communication between family members, allowing everyone to express their feelings, fears, and concerns.

Seek professional help: Consider involving a counsellor or therapist who specialises in working with children with cancer. They can provide guidance on coping strategies and address emotional challenges.

Connect with support groups: Joining support groups can offer comfort and a sense of belonging by connecting with other families going through similar experiences.

Financial and Social Assistance

Childhood blood cancer treatment can place a significant financial burden on families. However, there are resources available to provide financial and social assistance during this challenging time:

Insurance coverage: The family should review their health insurance policy to comprehend the coverage and identify potential out-of-pocket expenses. Consulting with their insurance provider is advisable to explore available assistance options.

Non-profit organisations: Many organisations offer financial assistance programmes specifically for families affected by childhood blood cancer. These programmes can help with medical bills, travel expenses, and other related costs.

Social workers: Hospital social workers can provide guidance on accessing financial assistance programmes, connecting with community resources, and navigating the healthcare system.

Procedure of Childhood Blood Cancer Treatment in Mumbai 

Childhood blood cancer affects many children across the Indian subcontinent. According to GLOBOCAN, almost 25,000 kids in India get told they have cancer each year, and about 9,000 of them have leukaemia. Thus, it is essential to understand the treatment options available for this condition to provide hope and support to those affected.

Step-by-step Explanation of the Chosen Treatment

In Mumbai, there are well-established medical facilities and experienced healthcare professionals who specialise in treating childhood blood cancer. Let's take a closer look at the step-by-step explanation of the chosen treatment procedure.

1. Diagnosis: The first step in treating childhood blood cancer is an accurate diagnosis. This involves various tests and evaluations, including blood tests, bone marrow aspiration, and biopsy. These tests help identify the specific type and stage of the cancer, enabling doctors to determine the most appropriate treatment plan.
2. Chemotherapy: The primary treatment for childhood blood cancer is chemotherapy. It involves the use of powerful medications to destroy cancer cells and prevent them from spreading further. Chemotherapy may be administered orally, intravenously, or through injections. It can be given in cycles, allowing time for the body to recover between treatments.
3. Radiation therapy: In some cases, radiation therapy may be recommended as part of the treatment plan. This involves using high-energy radiation beams to target and kill cancer cells. Radiation therapy is typically used when cancer has spread to the brain or spinal cord.
4. Stem cell transplant: For certain types of childhood blood cancer, a stem cell transplant may be necessary. This procedure involves replacing damaged or destroyed bone marrow with healthy stem cells from a donor or the patient themselves.

Anaesthesia and Monitoring

During certain procedures such as bone marrow aspiration or biopsy, anaesthesia may be used to ensure that children are comfortable and pain-free.

Throughout the treatment process, medical professionals closely monitor patients' vital signs and overall health status.

It's important to note that each child's treatment plan may vary based on their specific condition and response to treatment. The medical team in Mumbai will carefully assess and tailor the treatment approach to provide the best possible outcome for each child.

While the treatment process for childhood blood cancer can be challenging, it's crucial to remain positive. Advances in medical technology and research have significantly improved survival rates for children with this disease. Many children go on to live healthy, fulfilling lives after their treatment.

Childhood Blood Cancer (Childhood Leukaemia) Treatment Approaches

Childhood leukaemia is a serious and potentially life-threatening condition. Nevertheless, due to advancements in medical science, there is a positive outlook for effective treatment and improved chances of survival. Here, we will discuss some of the treatment approaches that are commonly used for childhood blood cancer.

Chemotherapy: This is the most common form of treatment for childhood leukaemia. It involves the use of powerful drugs to kill cancer cells and prevent their growth. Chemotherapy may be administered orally, through injections, or intravenously. It is often given in cycles, with breaks in between to allow the body to recover.

Radiation therapy: In some cases, radiation therapy may be used alongside chemotherapy to target specific areas affected by cancer cells. This treatment approach uses high-energy beams to destroy cancer cells and shrink tumours.

Stem cell transplant: For children with high-risk or relapsed leukaemia, a stem cell transplant may be recommended. This procedure involves replacing unhealthy bone marrow with healthy stem cells from a donor. The new stem cells can then produce healthy blood cells and help in the recovery process.

Targeted therapy: This type of treatment specifically targets cancer cells by blocking certain proteins or genes that are involved in their growth. Targeted therapy is often used in combination with other treatments for childhood leukaemia to maximise its effectiveness.

Immunotherapy: Immunotherapy is a promising new approach that helps boost the body's immune system to recognise and destroy cancer cells. It involves using substances (such as antibodies) that target specific markers on cancer cells, triggering an immune response against them.

It is important to note that each child's treatment plan will vary depending on the type and stage of their blood cancer. It is crucial to consult with a paediatric oncologist who specialises in childhood blood cancers to determine the most suitable treatment approach.

Chemotherapy for Childhood Blood Cancer 

Chemotherapy plays a crucial role in the medical treatment of childhood blood cancer. Let's closely examine the mechanisms of chemotherapy and the specific pharmaceutical agents used in the management of childhood leukaemia.

Understanding Chemotherapy: How it Works Against Cancer

Chemotherapy is a powerful treatment option used to combat childhood blood cancer. It involves the use of drugs to destroy cancer cells and prevent them from spreading further in the body. While the word "chemotherapy" can sound intimidating, it is important to understand how it works and its effectiveness in treating this disease.

Here's how chemotherapy works against childhood blood cancer:

Chemotherapy drugs are designed to target rapidly dividing cells, which includes cancer cells. These drugs work by interfering with the cell division process, preventing cancer cells from multiplying and spreading.

Chemotherapy can be administered in various ways, including oral medication, intravenous injections, or through a catheter placed directly into a large vein. The mode of administration will depend on the type and stage of the childhood blood cancer.

Chemotherapy is often given in cycles, with periods of treatment followed by rest periods to allow the body time to recover. This helps minimise side effects and maximise the effectiveness of the treatment.

As chemotherapy drugs circulate throughout the body, they not only attack cancer cells but also target healthy cells that divide quickly. This can lead to side effects such as hair loss, nausea, fatigue, and increased susceptibility to infections. However, these side effects are usually temporary and can be managed with supportive care.

It is important to remember that while chemotherapy can be challenging for children and their families, it offers hope for successful treatment of childhood blood cancer. Advancements in chemotherapy protocols have significantly improved survival rates over the years, giving children a better chance at recovery.

By understanding how chemotherapy works against childhood blood cancer and staying informed about the available treatment options, families can make informed decisions and play an active role in their children's healthcare journey.

Chemotherapy Drugs Used in Childhood Leukaemia Treatment

Chemotherapy is one of the primary treatment options for childhood leukaemia, and it involves the use of specific drugs to target and destroy cancer cells. Here are some common chemotherapy drugs used in childhood leukaemia treatment:

1. Methotrexate: This drug works by interfering with the growth of cancer cells and preventing them from multiplying. It is often administered intravenously or orally.
2. Vincristine: Vincristine is a drug that disrupts the formation of microtubules in cancer cells, impairing their ability to divide and grow. It is usually given intravenously.
3. Daunorubicin: Daunorubicin is an anthracycline chemotherapy drug that inhibits DNA replication in cancer cells, leading to their destruction. It is typically administered through an intravenous infusion.
4. Asparaginase: This enzyme-based drug deprives cancer cells of asparagine, an essential amino acid for their growth and survival. Asparaginase can be given intravenously or intramuscularly.
5. Prednisone: Prednisone belongs to a class of drugs called corticosteroids and has anti-inflammatory properties that help reduce inflammation caused by leukaemia cells. It is commonly taken orally.

It's important to note that the combination of chemotherapy drugs used may vary depending on the type and stage of childhood leukaemia. While chemotherapy can have side effects, the potential benefits outweigh these temporary discomforts. The survival rates for childhood leukaemia have significantly improved over the years, thanks to ongoing research and advancements in treatment options.

Radiation Therapy in Childhood Blood Cancer Treatment 

Radiation therapy plays a crucial role in the treatment of childhood blood cancers, such as childhood leukaemia. In this section, we will explore the importance of radiation therapy and its effectiveness in combating this devastating disease.

Radiation therapy utilises high-energy beams to target and destroy cancer cells.

It is often used in combination with other treatments like chemotherapy or surgery to increase the chances of a successful outcome.

The main goal of radiation therapy for childhood blood cancer is to eliminate remaining cancer cells after chemotherapy or reduce tumour size before surgery.

Radiation therapy can be administered externally or internally, depending on the specific needs of the patient.

• External beam radiation is a technique that involves directing precisely controlled radiation beams from outside the body toward the affected area. This approach ensures that the radiation precisely targets the tumour while minimising exposure to surrounding healthy tissue. It is frequently used when treating cancers in various parts of the body, allowing for effective and localised treatment.
• On the other hand, internal radiation, or brachytherapy, is an approach where radioactive materials are placed directly inside or in close proximity to the tumour site. This method enables the delivery of a high dose of radiation directly to the cancerous cells while sparing nearby healthy tissues.

Radiation therapy helps destroy cancer cells and prevents their ability to grow and multiply.

It can also alleviate symptoms and improve the quality of life for children undergoing treatment.

Childhood Blood Cancer Risk Factors

Childhood blood cancer, while multifactorial in its aetiology, presents certain identifiable risk factors, including:

Genetic predisposition: Genetic mutations, notably germline mutations in critical hematopoietic genes, contribute to an increased susceptibility to childhood blood cancer. A familial history marked by a lineage of affected individuals underscores this risk.

Environmental factors: Exposure to specific environmental agents during crucial developmental periods, such as prenatal or early childhood phases, may potentiate the risk of childhood blood cancer. Notable culprits encompass ionising radiation, chemical carcinogens, and infectious agents.

Down syndrome: Children diagnosed with Down syndrome exhibit a heightened predisposition to childhood blood cancer. The underlying genetic abnormalities associated with Down syndrome are thought to play a contributory role.

Immune system disorders: Conditions characterised by immunodeficiency, including HIV/AIDS and post-organ transplant immunosuppression, can elevate the susceptibility to childhood blood cancer.

Previous cancer treatment: Certain modalities of cytotoxic therapy, particularly radiation and chemotherapeutic agents utilised in the management of unrelated childhood malignancies, may predispose individuals to the development of secondary childhood blood cancer in subsequent years.

Parents concerned about their child's risk profile should engage in a comprehensive discussion with a doctor. Such consultations can facilitate the implementation of proactive measures, including genetic counselling, early diagnostic vigilance, and tailored screening protocols. In adopting an informed and vigilant approach, the impact of childhood blood cancer on affected children and their families can be potentially mitigated.

Childhood Blood Cancer (Childhood Leukaemia) Side Effects

Being diagnosed with childhood blood cancer is undoubtedly a challenging and difficult experience for both the child and their family. While the treatment of childhood leukaemia has improved significantly in recent years, it's important to be aware of the potential side effects that may accompany the disease and its treatments.

Hair loss

Hair loss is a widely recognised side effect of childhood leukaemia treatment, primarily attributed to the impact of chemotherapy drugs on rapidly dividing cells, including those in hair follicles.

Parents should provide reassurance to the child, emphasising that hair loss is a temporary consequence of the treatment and that their hair will regrow after the therapy concludes.

To boost the child's confidence and comfort, it's advisable to encourage them to explore various options for head coverings, such as scarves, hats, or even wigs, which can help maintain a sense of normalcy and reduce self-consciousness during this period.

Nausea and Vomiting 

Nausea and vomiting are common side effects of chemotherapy, impacting patients to varying degrees based on the chemotherapy drugs' type and dosage.

Anti-nausea medications should be discussed with the healthcare team to effectively manage these symptoms in children.

Promote a diet of smaller, more frequent meals for the child and discourage the consumption of strongly flavoured or odorous foods that may trigger nausea.

Collaborating with medical professionals can enhance the child's comfort and well-being during chemotherapy, addressing these side effects proactively and comprehensively.

Loss of Appetite

A common side effect of childhood leukaemia treatment is a loss of appetite, often attributed to the impact of chemotherapy drugs on taste buds and overall appetite regulation.

To address this challenge, parents can consider offering the child smaller, more frequent meals throughout the day, which can be less overwhelming and more enticing than large meals.

It's essential to create a supportive environment by encouraging the child to consume their favourite foods, as well as exploring new food options that align with their preferences. This approach can help maintain adequate nutrition and enhance the child's overall well-being during treatment.

Diarrhoea 

Diarrhoea can be a side effect of childhood leukaemia treatment, often induced by chemotherapy or other prescribed medications.

Hydration is vital; ensure the child drinks plenty of fluids to prevent dehydration.

Opt for a mild and bland diet, avoiding foods that may exacerbate diarrhoea, such as spicy or greasy options.

Open a dialogue with the medical team to discuss over-the-counter medications that can effectively manage diarrhoea in the child, as their guidance is crucial for tailored treatment and minimising discomfort.

While these side effects can be overwhelming, it's crucial to remember that they are temporary and a small price to pay for potentially life-saving treatment. The medical community continues to make significant advancements in the treatment of childhood leukaemia, improving survival rates and better quality of life for young patients.

Recovery and Aftercare 

Recovery and aftercare for childhood leukaemia encompass a comprehensive approach to ensure the child's long-term well-being. It involves medical monitoring, emotional support, and lifestyle adjustments. Regular check-ups, adherence to medical recommendations, and a nurturing environment play vital roles in the child's ongoing journey to recovery.

Pain Management and Medications

When it comes to managing pain associated with childhood blood cancer, doctors employ a variety of approaches tailored to each child's needs. Here are some key points to consider:

Pain medications: Children undergoing treatment for blood cancer may experience various types of pain, such as bone pain or discomfort during procedures like bone marrow biopsies. The doctor will often prescribe pain medications to help manage these symptoms. These may include over-the-counter options like acetaminophen or stronger prescription medications if necessary.

Non-pharmacological interventions: In addition to medication, non-pharmacological approaches can also be effective in managing pain. These may include relaxation techniques, distraction techniques (such as playing games or listening to music during procedures), physical therapy exercises, and complementary therapies like acupuncture or massage.

Supportive care: Alongside pain management, supportive care plays a crucial role in helping children cope with the challenges of blood cancer treatment. This includes providing emotional support for both the child and their family, as well as ensuring adequate nutrition and hydration to maintain overall well-being.

It's important to work closely with the medical team to find the most effective pain management plan for each child. Regular communication and open discussions about any concerns or changes in pain levels are crucial to ensure that the treatment plan is optimised for maximum comfort and relief.

Follow-up Visits 

Regular follow-up appointments are vital for the successful recovery from childhood blood cancers like leukaemia. These visits allow the doctor to monitor the child's progress, detect any potential complications or relapse, and provide necessary support and guidance to ensure the child's continued well-being.

During follow-up visits, the healthcare team will typically:

Conduct physical examinations to assess the child's overall health and check for any signs of recurrence or late effects from treatment.

Perform blood tests to monitor blood counts and check for any abnormalities.

Conduct imaging tests, such as X-rays or ultrasounds, to evaluate specific areas of concern.

Discuss any symptoms or concerns that the child or their caregivers may have.

Provide education and counselling on lifestyle changes, healthy habits, and potential long-term effects of treatment.

Address the emotional and psychological needs of the child and their family members.

It is important for parents to actively participate in these follow-up visits and communicate any changes or concerns regarding the child's health. These visits serve not only as a means of medical evaluation but also as an opportunity for families to receive ongoing support and reassurance from the healthcare team.

By attending regular follow-up visits, families can have peace of mind knowing that their child's health is being carefully monitored and managed.

Conclusion

In summary, childhood blood cancer encompasses a range of challenges, from diagnosis to treatment and recovery. Progress in research and treatment protocols has significantly improved the outlook for affected children. Timely, comprehensive care, guided by a dedicated healthcare team and supported by families and networks, is essential. Specific treatments may vary, but the goal remains consistent: achieving remission and nurturing the child's long-term well-being. Monitoring, emotional support, and post-treatment follow-up are integral components of the journey towards recovery. While challenges persist, the collaborative efforts of medical professionals, families, and support networks ensure that children with blood cancer can look forward to healthier, happier futures.

Frequently Asked Questions

1. What Factors Determine The Most Suitable Treatment Approach for a Child With Blood Cancer?

The choice of treatment for a child with blood cancer depends on several factors, including the type and subtype of cancer, the child's age and overall health, the stage of the disease, and the potential side effects of treatment. A multidisciplinary team of medical professionals assesses these factors to develop a personalised treatment plan that may include chemotherapy, radiation therapy, stem cell transplantation, or other therapies.

2. Can Childhood Blood Cancer Be Cured?

Many cases of childhood blood cancer, including leukaemia, are curable with appropriate treatment. The likelihood of a cure varies depending on the type of cancer, its stage at diagnosis, and the response to therapy. Advances in medical science and treatment protocols have significantly improved the prognosis for children with blood cancer, and many go on to lead healthy lives after successful treatment.

3. Is Blood Cancer Common in Children?

While relatively rare compared to adult cases, blood cancer does occur in children. Leukaemia, including acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML), is the most common type of childhood cancer. The incidence of blood cancer in children varies by geographic region and population demographics.

4. What is The Approximate Cost of Treating Childhood Blood Cancer?

The cost of treating childhood blood cancer can vary widely depending on factors such as the type of cancer, the stage at diagnosis, the treatment modalities used, and the duration of treatment. Comprehensive care, including surgery, chemotherapy, radiation therapy, and supportive care, can be financially burdensome. Costs may be partially covered by health insurance, government programmes, or charitable organisations, but families often face substantial out-of-pocket expenses.

5. What is The Most Common Childhood Leukaemia?

The most common childhood leukaemia is Acute Lymphoblastic Leukaemia (ALL). It accounts for a significant portion of childhood blood cancers and usually occurs between the ages of 2 and 5. ALL originates in the bone marrow and affects white blood cells, and with timely and appropriate treatment, it has a high cure rate.

6. How Long Does Childhood Blood Cancer Treatment Typically Last?

The duration of treatment for childhood blood cancer varies depending on several factors, including the type of cancer, the stage at diagnosis, the specific treatment plan, and the individual patient's response to therapy. Treatment can last from several months to several years. After initial intensive treatment, children often require follow-up care and monitoring to assess their long-term health and well-being.

7. Who is at Risk For Childhood Leukaemia?

The exact cause of childhood leukaemia is not well understood, but some risk factors have been identified. These include genetic factors, exposure to certain environmental toxins, prior exposure to radiation or chemotherapy, and certain medical conditions like Down syndrome. However, most children with leukaemia do not have identifiable risk factors, and the disease is not typically linked to lifestyle choices or behaviours.

Related Blogs

• Blood Cancer: Unravelling the Symptoms and Pioneering Treatments through Bone Marrow Transplant
• Best Pediatric Bone Marrow Transplant
• Bone Marrow Transplant - Know More About & Its Types
• Bone Marrow Transplantation (BMT) or Stem Cell Transplantation (SCT)